A Study of Capecitabine (Xeloda) in Patients With Metastatic Colorectal Cancer

NCT02567331 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hoffmann-La Roche